Shares of Oxford Biomedica plc (LON:OXB – Get Rating) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 521.56 ($6.30) and traded as low as GBX 391.50 ($4.73). Oxford Biomedica shares last traded at GBX 399.50 ($4.83), with a volume of 160,722 shares trading hands.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada reaffirmed an “outperform” rating and issued a GBX 1,070 ($12.93) price target on shares of Oxford Biomedica in a research note on Thursday, June 30th.
Oxford Biomedica Stock Down 4.5 %
The company has a market capitalization of £384.37 million and a P/E ratio of 1,997.50. The company has a current ratio of 4.92, a quick ratio of 4.52 and a debt-to-equity ratio of 4.99. The firm’s 50 day moving average price is GBX 461.48 and its two-hundred day moving average price is GBX 521.56.
Oxford Biomedica Company Profile
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes.
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.